Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ardana acquires global rights to Teverelix

April 7, 2004

Promising tubulin-binding compound with antimitotic activity

April 7, 2004

RS-5444, a PPARgamma agonist, shows high affinity against thyroid tumor growth

April 7, 2004

CX-3543, a novel c-Myc oncogene inhibitor, shows efficacy in vivo

April 7, 2004

Inhibitors of CDK2 and other kinases emerge from Cyclacel R&D

April 7, 2004

Novel protein kinase inhibitors in early development at Vertex

April 7, 2004

Integrin antagonists show good potency, selectivity and bioavailability

April 7, 2004

Antitumor effects of the chemosensitizer phenoxodiol in prostate and ovarian cancer

April 7, 2004

TLK-286 increases the efficacy of antitumor drugs in vitro

April 7, 2004

Decitabine delays progression to AML in patients with myelodysplastic syndromes

April 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...